Astrid M van Huizen
Overview
Explore the profile of Astrid M van Huizen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study
Caron A, van Huizen A, Musters A, Gerbens L, Middelkamp Hup M, Flohr C, et al.
J Eur Acad Dermatol Venereol
. 2024 Aug;
39(2):331-339.
PMID: 39087636
Background: Despite the widespread off-label use of methotrexate (MTX) for the treatment of atopic dermatitis (AD), there is limited high-quality evidence on dosing regimens and existing guidelines do not provide...
2.
Caron A, Bloem M, El Khattabi H, de Waal A, van Huizen A, Denswil N, et al.
J Dermatolog Treat
. 2023 Dec;
35(1):2292962.
PMID: 38124505
Methotrexate is an off-label therapy for atopic dermatitis. A lack of consensus on dosing regimens poses a risk of underdosing and ineffective treatment or overdosing and increased risk of side...
3.
van Huizen A, van der Kraaij G, Busard C, Ouwerkerk W, van den Reek J, Menting S, et al.
J Eur Acad Dermatol Venereol
. 2023 Apr;
37(9):1815-1824.
PMID: 37014287
Background: Anti-drug antibodies (ADA) are formed in patients treated with adalimumab (ADL). This might increase clearance of ADL, potentially causing a (secondary) non-response. Combination therapy of ADL and methotrexate (MTX)...
4.
van Huizen A, Sikkel R, Caron A, Menting S, Spuls P
J Dermatolog Treat
. 2022 Aug;
33(8):3104-3118.
PMID: 36043844
Background: Methotrexate (MTX) is a systemic treatment for plaque-type psoriasis. At the time of approval, no dose-ranging studies were performed. Nowadays, a uniform dosing regimen is lacking. This might contribute...
5.
van Huizen A, Menting S, Gyulai R, Iversen L, van der Kraaij G, Middelkamp-Hup M, et al.
JAMA Dermatol
. 2022 Mar;
158(5):561-572.
PMID: 35353175
Importance: A clear dosing regimen for methotrexate in psoriasis is lacking, and this might lead to a suboptimal treatment. Because methotrexate is affordable and globally available, a uniform dosing regimen...
6.
van Huizen A, Vermeulen F, Bik C, Borgonjen R, Karsch S, Kuin R, et al.
J Dermatolog Treat
. 2021 Aug;
33(4):1947-1966.
PMID: 34425719
If an authorized drug is prescribed for a use that is not described in the Summary of Product Characteristics, this is defined as 'off-label use.' Methotrexate is often used off-label...